Expression of vascular endothelial growth factor in patients with acute myocardial infarction

Journal of the American College of Cardiology

Volumn 35, Issue 4, 2000, Pages 968-973

  Hojo, Yukihiro ^a   Ikeda, Uichi ^a   Zhu, Yun ^a   Okada, Motoi ^a   Ueno, Shuichi ^a   Arakawa, Hiroshi ^a   Fujikawa, Hideyuki ^a   Katsuki, Taka Aki ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; MITOGENIC AGENT; VASCULOTROPIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD LEVEL; CELL CULTURE; CELL DENSITY; CELL ISOLATION; CELL LEVEL; CELL SPECIFICITY; CLINICAL ARTICLE; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HEART MUSCLE INJURY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CELLS, CULTURED; CORONARY ARTERY BYPASS; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; MONOCYTES; MYOCARDIAL INFARCTION; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 0034654487     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00632-4     Document Type: Article

References (32)

1. Waltenberger J. Modulation of growth factor action implication for the treatment of cardiovascular diseases . Circulation. 96:1997;4083-4094.
2. Ross R. The pathogenesis of atherosclerosis a perspective for the 1990s . Nature. 362:1993;801-809.
3. Banai S., Jaklitsch M.T., Shou M., et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 89:1994;2183-2189.
4. Pearlman J.D., Hibberd M.G., Chuang M.L., et al. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nature Med. 1:1995;1085-1089.
5. Harada K., Friedman M., Lopez J.J., et al. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol. 270:1996;H1791-H1802.
6. Yanagisawa-Miwa A., Uchida Y., Nakamura F., et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science. 257:1992;1401-1403.
7. Lazarous D.F., Shou M., Scheinowitz M., et al. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation. 94:1996;1074-1082.
8. Brown L.F., Yeo K.-T., Berse B., et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med. 176:1992;1375-1379.
9. Takeshita S., Zheng L.P., Kearney M., et al. Therapeutic angiogenesis a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model . J Clin Invest. 93:1994;662-670.
10. Baumgartner I., Pieczek A., Manor O., et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 97:1998;1114-1123.
11. Seko Y., Imai Y., Kamijukkoku S., et al. Serum levels of vascular endothelial growth factor in patients with acute myocardial infarction undergoing reperfusion therapy. Clin Sci. 92:1997;453-454.
12. Möhle R., Green D., Moore M.A.S., Nachman R.L., Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA. 94:1997;663-668.
13. Berse B., Brown L.F., Water L.V.D., Dvorak H.F., Senger D.R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell. 3:1992;211-220.
14. Taichman N.S., Young S., Cruchley A.T., Tayler P., Paleolog E. Human neutrophils secrete vascular endothelial growth factor. J Leukoc Biol. 62:1997;397-400.
15. Kasser I.S., Kennedy J.W. Measurement of left ventricular volumes in man by single-plane cineangiocardiography. Invest Radiol. 4:1969;83-90.
16. Kawamoto A., Kawata H., Akai Y., et al. Serum levels of VEGF and basic FGF in the subacute phase of myocardial infarction. Int J Cardiol. 67:1998;47-54.
17. Li J., Brown L.F., Hibberd M.G., Grossman J.D., Morgan J.P., Simons M. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol. 270:1996;H1803-H1811.
18. Ferrara N., Winer J., Burton T. Aortic smooth muscle cells express and secrete vascular endothelial growth factor. Growth Factors. 5:1991;141-148.
19. Liu Y., Cox S.R., Morita T., Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ Res. 77:1995;638-643.
20. Tashiro H., Shimokawa H., Yamamoto K., et al. Monocyte-related cytokines in acute myocardial infarction. Am Heart J. 130:1995;446-452.
21. Kukielka G.L., Smith W., Manning A.M., Youker K.A., Michael L.H., Entman M.L. Induction of interleukin-6 synthesis in the myocardium potential role in potreperfusion inflammatory injury . Circulation. 92:1995;1866-1875.
22. Herskowitz A., Choi S., Ansari A., Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol. 146:1995;419-428.
23. Wan S., DeSmet J.M., Barvais L., Goldstein M., Vincent J.L., LeClerc J.L. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 112:1996;806-811.
24. Guillén I., Blanes M., Gómez-Lechón M.J., Castell J.V. Cytokine signaling during myocardial infarction sequential appearance of IL-1β and IL-6 . Am J Physiol. 269:1995;R229-R235.
25. Kanda T., Hirao Y., Oshima S., Yuasa K., Taniguchi K., Nagai R., Kobayashi I. Interleukin-8 as a sensitive marker of unstable coronary artery disease. Am J Cardiol. 77:1996;304-307.
26. Kukielka G.L., Smith W., LaRosa G.J., et al. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest. 95:1995;89-103.
27. Neumann F.J., Ott I., Gawaz M., et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation. 92:1995;748-755.
28. Ikeda U., Ohkawa F., Seino Y., et al. Serum interleukin-6 levels were elevated in acute myocardial infarction. J Mol Cell Cardiol. 24:1992;579-584.
29. Dembinska-Kiec A., Dulak J., Partyka L., Huk I., Mailnski T. VEGF-nitric oxide reciprocal regulation. Nature Med. 3:1997;1177.
30. Brogi E., Wu T., Namiki A., Isner J.M. Indirect angiogenetic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation. 90:1994;649-652.
31. Shinozaki K., Shinohara T., Mochizuki N., et al. Expression of vascular endothelial growth factor in human myocardial infarction. Heart Vessels. 11:1996;113-122.
32. Pearlman J.D., Hibberd M.G., Chuang M.L., et al. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nature Med. 1:1995;1085-1089.